Clinical Trials Insight: 700033593
Latest Information Update: 15 May 2008
At a glance
- Drugs SEP 228432 (Primary)
- Indications Depressive disorders
- Focus Adverse reactions
- Sponsors Sunovion Pharmaceuticals
Most Recent Events
- 15 May 2008 New trial record.